CX Institutional purchased a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,229 shares of the technology company's stock, valued at approximately $844,000.
Several other large investors have also recently bought and sold shares of DOX. Choreo LLC acquired a new stake in shares of Amdocs during the 4th quarter worth about $402,000. Empowered Funds LLC lifted its position in Amdocs by 8.9% during the fourth quarter. Empowered Funds LLC now owns 14,270 shares of the technology company's stock worth $1,215,000 after acquiring an additional 1,165 shares during the last quarter. Entropy Technologies LP acquired a new stake in Amdocs during the fourth quarter worth approximately $238,000. Savant Capital LLC boosted its holdings in shares of Amdocs by 17.2% during the fourth quarter. Savant Capital LLC now owns 3,105 shares of the technology company's stock worth $264,000 after acquiring an additional 456 shares during the period. Finally, Two Point Capital Management Inc. grew its position in shares of Amdocs by 1.0% in the fourth quarter. Two Point Capital Management Inc. now owns 34,101 shares of the technology company's stock valued at $2,922,000 after purchasing an additional 352 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a report on Saturday, June 7th.
Check Out Our Latest Stock Analysis on Amdocs
Amdocs Stock Performance
NASDAQ:DOX traded down $2.13 during mid-day trading on Friday, reaching $91.95. 732,525 shares of the company's stock were exchanged, compared to its average volume of 673,280. Amdocs Limited has a one year low of $74.41 and a one year high of $94.61. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The business's fifty day simple moving average is $88.70 and its two-hundred day simple moving average is $87.64. The firm has a market capitalization of $10.38 billion, a PE ratio of 21.33, a price-to-earnings-growth ratio of 1.47 and a beta of 0.52.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its earnings results on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, topping the consensus estimate of $1.71 by $0.07. The company had revenue of $1.13 billion for the quarter, compared to analysts' expectations of $1.12 billion. Amdocs had a net margin of 10.19% and a return on equity of 18.89%. The business's revenue for the quarter was down 9.4% on a year-over-year basis. During the same period last year, the firm earned $1.56 earnings per share. Analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.
Amdocs Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Monday, June 30th will be given a dividend of $0.527 per share. The ex-dividend date is Monday, June 30th. This represents a $2.11 annualized dividend and a dividend yield of 2.29%. Amdocs's dividend payout ratio is 44.21%.
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.